Laquinimod, a new oral drug for multiple sclerosis

B. Mark Keegan; Brian G. Weinshenker

doi:10.1016/S0140-6736(08)60894-6

Laquinimod, a new oral drug for multiple sclerosis

B. Mark Keegan, Brian G. Weinshenker

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	2059-2060
Number of pages	2
Journal	The Lancet
Volume	371
Issue number	9630
DOIs	https://doi.org/10.1016/S0140-6736(08)60894-6
State	Published - 2008

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(08)60894-6

Cite this

@article{aa64db9792d34431b8156e05d3168ac5,

title = "Laquinimod, a new oral drug for multiple sclerosis",

author = "Keegan, {B. Mark} and Weinshenker, {Brian G.}",

year = "2008",

doi = "10.1016/S0140-6736(08)60894-6",

language = "English (US)",

volume = "371",

pages = "2059--2060",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9630",

}

TY - JOUR

T1 - Laquinimod, a new oral drug for multiple sclerosis

AU - Keegan, B. Mark

AU - Weinshenker, Brian G.

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=45249089662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45249089662&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(08)60894-6

DO - 10.1016/S0140-6736(08)60894-6

M3 - Comment/debate

C2 - 18572062

AN - SCOPUS:45249089662

SN - 0140-6736

VL - 371

SP - 2059

EP - 2060

JO - The Lancet

JF - The Lancet

IS - 9630

ER -

Laquinimod, a new oral drug for multiple sclerosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this